Bowel cancer is uncommon in younger adults and we are not going to pretend otherwise. It is also rising faster in this age group than any other, NHS screening does not start until 50, and the most consistent complaint from younger patients is not being taken seriously the first time.
Around 1 in 20 UK bowel cancer cases occur in people under 50. That is uncommon. It is not rare enough for age on its own to settle the question, which is why national guidance sets no age limit on who can be assessed with a stool test.
The threshold does not move either. A result of 25 µg Hb/g means the same amount of blood whether you are 28 or 68. Age is context for interpreting a result. It is not a filter for who gets one.
The practical problem for younger adults is being believed. In Bowel Cancer UK’s survey of more than 1,000 younger patients, 43% had visited their GP three or more times before being referred. A number is harder to talk past than a description of symptoms.
These findings need examining rather than testing, at any age. Please speak to a doctor rather than ordering a kit if any apply:
If you have already been dismissed once, that is a reason to ask again rather than to stop asking. You can book a consultation with our GP if you want a second opinion.
Including the uncomfortable ones, and the honest caveats on where each figure comes from.
Uncommon, and not rare enough for age alone to close the question. NHS screening does not begin until 50, which leaves everyone below that with no routine check at all.
An American Cancer Society led analysis in The Lancet Oncology found early onset bowel cancer rising in 27 of 50 countries studied. England had the fourth fastest increase globally, around 3.6% a year in the decade to 2017, faster than any other country in Europe.
From Bowel Cancer UK’s survey of more than 1,000 younger patients. It is a self selected survey rather than population data, so treat it as evidence about experience rather than an incidence rate. It is consistent with what younger patients report everywhere.
Guidance says explicitly that there is not enough evidence to vary the threshold by age, sex or ethnicity. Adults of all ages are assessed against the same number. That is deliberate rather than an oversight.
Bleeding gets attributed to haemorrhoids, changed habit to IBS, and tiredness to being busy. All three are usually right. Being usually right is exactly what makes the exception hard to spot.
If you are 31 and you have noticed some blood, the overwhelmingly likely explanation is not cancer. Around 1 in 20 UK bowel cancer cases occur in people under 50, and against a population of tens of millions of under 50s, the individual probability is small.
Any page that skips past that in order to sell you a test is not being straight with you. So: the base rate is low, and it should be part of how you think about this.
The problem is what gets done with that fact. A low base rate is a good reason to expect a benign explanation. It is not a good reason to stop looking for one, and it is not a good reason to decline to measure anything. Those are different decisions and they routinely get collapsed into one.
Early onset bowel cancer, meaning cases diagnosed under 50, is rising. An American Cancer Society led analysis published in The Lancet Oncology found rates increasing in 27 of the 50 countries and territories studied. England had the fourth fastest rise in the world, roughly 3.6% a year over the decade to 2017, faster than anywhere else in Europe. Bowel Cancer UK reports that among adults aged 25 to 49, cases have increased by more than half over the past 25 years.
Nobody yet knows why with confidence. Diet, obesity, the microbiome and early life exposures are all under investigation, and most younger patients have no family history and no obvious risk factor at all. What matters practically is that the assumption underneath “you are too young for this” is drifting, and clinical habits move more slowly than the data does.
The most consistent finding about younger patients is not biological. It is about the pathway. In Bowel Cancer UK’s 2020 survey of more than 1,000 younger people with bowel cancer, 43% had visited their GP three or more times before being referred, and around one in six had been five or more times.
That is survey data from people who already have the diagnosis, gathered through patient networks, so it is not an incidence rate and it cannot tell you how often younger patients are correctly reassured. What it does tell you is what the experience looks like when it goes wrong, and it goes wrong in a recognisable way. Symptoms get attributed to haemorrhoids, to IBS, to stress, to a new job, to being tired. Those attributions are usually correct. That is precisely the trap.
The strongest argument for testing at this age is not that the test is more accurate in younger people. It is that a measurement is a different kind of object from a description.
“I have had some bleeding and my bowels have been off” invites interpretation, and interpretation is where age bias operates. “My FIT is 46” does not. It is a fact about your bowel that has to be dealt with on its own terms. National guidance sets the threshold at 10 µg Hb/g for symptomatic patients regardless of age, so a raised figure in a 30 year old means the same thing on paper as it does in a 60 year old.
Where age legitimately matters is in what happens next, and how urgently. It shapes what else is considered, whether a family history assessment is warranted, and how quickly things move. It does not determine whether you are entitled to be measured.
That changes the picture and a stool test is not the right tool on its own. Someone with a first degree relative diagnosed under 50, or two affected first degree relatives, meets criteria for colonoscopic surveillance rather than periodic stool testing. See our page on family history of bowel cancer before you order anything.
Your exact figure rather than a positive or negative, read against 10 µg Hb/g, with a written GP report and a telephone consultation included whatever the result. If your number is raised we write to your NHS GP with the figure and the laboratory report, which is a more difficult document to set aside than a description of symptoms.
And if you have symptoms right now, book the consultation rather than ordering a kit on its own. Being under 50 with symptoms is a situation that deserves a conversation, not just a sample pot.
Two are population statistics. One is survey data from patients who already had a diagnosis. We have said which is which.
The case for testing under 50 is real. It is also narrower than a marketing page would tell you.
You are less likely to, and you are not exempt. Around 1 in 20 UK bowel cancer cases occur in people under 50, and rates in younger adults have been rising: an American Cancer Society led analysis in The Lancet Oncology found England had the fourth fastest increase globally, about 3.6% a year in the decade to 2017. National guidance places no age limit on who can be assessed with a stool test.
No, and that is deliberate. Guidance says there is not enough evidence to vary the threshold by age, sex or ethnicity. The test measures how much blood is in your sample, and that is a fact about your bowel rather than about your age. What age legitimately changes is the likelihood that blood means cancer, and therefore what happens next, not where the test flags something.
Those are the most likely explanations and your GP is probably right. But in Bowel Cancer UK’s survey of more than 1,000 younger patients with bowel cancer, 43% had visited three or more times before being referred. That is survey data from people who already had a diagnosis, so it does not tell you how often reassurance is correct. It does tell you that if your symptoms are persisting, going back is reasonable, and an objective number is a useful thing to take with you.
NHS bowel cancer screening in England, Scotland and Wales invites people aged 50 to 74 every two years. Northern Ireland currently starts at 60. Screening programmes are designed around population level cost effectiveness and colonoscopy capacity, and extending them downwards would require a very large increase in colonoscopy provision. That is a resource decision about a population, not a statement that nothing happens below 50.
If you have symptoms now, see a doctor. Being under 50 with symptoms is a situation that benefits from someone taking a history and examining you, not just a sample pot. Our consultation is £50 and we can arrange the test as part of it. If you feel well and want a baseline, or you have been assessed already and want your own number, the kit on its own is reasonable.
That changes things and a stool test on its own is probably not the right answer. Someone with one first degree relative diagnosed under 50, or two affected first degree relatives, meets criteria for referral and colonoscopic surveillance rather than periodic stool testing. Read our family history page before ordering.
Figures are drawn from the sources above. Framing and commentary are the author’s own. Written and reviewed by Dr Rhea Bhadresha, GP. Last reviewed August 2026.
Your exact figure read against the same threshold used for every other adult, with a written GP report and a telephone consultation included.
Your exact FIT figure, a written GP report and a telephone consultation are all included, whatever the number turns out to be. A one-off test with no subscription and nothing recurring.